Karyopharm to participate at barclays 26th annual global healthcare and leerink partners global biopharma conferences

Newton, mass. , march 6, 2024 /prnewswire/ -- karyopharm therapeutics inc. (nasdaq: kpti), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that the company's senior management team will participate in the leerink partners global biopharma conference on tuesday, march 12, 2024 and present at the barclays 26th annual global healthcare conference in a fireside chat on wednesday, march 13, 2024 at 9:00 a.m.
KPTI Ratings Summary
KPTI Quant Ranking